Post-earnings recap
Reported
Thu, Oct 27, 2011
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
75%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
AstraZeneca reported better-than-expected earnings per share, which led to a positive stock reaction, with shares rising by 1.76%. However, there was no revenue figure provided, and without further commentary from management, it's difficult to assess the broader implications. Investors may be cautiously optimistic based on the EPS beat alone.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.71 | N/A | +1.60% |
| Revenue | N/A | N/A | — |
No transcript is on record, so the analysis is based solely on numerical results.